New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register

OPTOMED PLC STOCK EXCHANGE RELEASE 25 September 2023, at 10.00 a.m. EEST

New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register

A total of 1,589,042 new shares subscribed for in Optomed Plc’s directed share issue have been registered into the Finnish Trade Register today, on 25 September 2023. After the registration of the new shares, the company will have 18,130,397 shares in total of which 353,973 shares in treasury.

The new shares produce the right to dividends and other distribution of assets as well as other shareholder rights as of this registration date.

The new shares will be admitted to trading on the official list of Nasdaq Helsinki Ltd today.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Distribution

Nasdaq Helsinki Ltd

Principal media

www.optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.